Data Characteristics
Peptide drug data originates from drug research and development reports, clinical trial documents, patent literature, academic papers, and various compound databases. These documents typically include complex molecular structures, pharmacokinetic (PK) and pharmacodynamic (PD) data, in vitro/in vivo experimental results, mechanism of action descriptions, and toxicology information. Data update frequencies vary. Patents and academic papers may see significant monthly or quarterly additions, while clinical trial data updates are less frequent, often on an annual basis. Document structures focus on peptide sequences, modification types, purity, and synthesis methods, often accompanied by detailed experimental conditions and results. Units commonly used include µM and nM for concentration, mg/kg for dosage, and hours and days for time.
Constraints Imposed by These Characteristics on Vector Models and Indexing
The highly specialized and structurally diverse nature of peptide drug data challenges vector models in semantic understanding and feature extraction. Non-textual information, such as molecular structures and chemical modifications, requires special encoding or representation for effective vectorization. Descriptions of drug mechanisms of action involve complex biological pathways and interactions, requiring models to capture deep semantic relationships. Patents and papers often contain numerous abbreviations and specialized terminology, necessitating strong domain vocabulary understanding from the model. Varying data update frequencies demand indexing strategies that balance the efficiency of high-frequency incremental updates with low-frequency full updates. Additionally, numerical information within PK/PD data requires models to effectively associate numerical values with textual descriptions to support precise consultative recall.
Configuration Settings
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 500–800 characters (characters) | Balances the completeness of peptide sequences, experimental results, and discussions, preventing truncation of critical information. |
Chunk Overlap Length (Segment Overlap Length) | 50–100 characters (characters) | Ensures contextual continuity and retains necessary associative information at segment boundaries. |
Recall count (Recall Count) | 8–12 entries (items) | Balances recall breadth with the computational cost of subsequent reranking, ensuring sufficient relevant documents are initially recalled. |
Similarity threshold (Similarity Threshold) | Calibrated by actual measurement 0.75–0.85 | Determined through small-sample testing based on actual business needs, preventing recall of irrelevant content or omission of key information. |
Rerank result count (Rerank Return Count) | 3–5 entries (items) | Focuses on the most relevant and precise information presented to the user, reducing the user's burden of filtering. |
ENABLE_IMAGE_VECTORIZATION | true | Peptide drug documents often contain molecular structure diagrams and experimental data charts. Enabling image vectorization helps in comprehensively understanding content. |
Common Pitfalls
- Knowledge base query results show a large number of irrelevant or low-relevance documents. This may be due to inappropriate segmentation strategies, leading to dilution of key information or loss of context.
- Some specialized terms or molecular structure information cannot be effectively retrieved. This typically occurs when the chosen vector model lacks sufficient encoding capability for specialized vocabulary and non-textual information in the biomedical domain.
- System errors or import timeouts occur when importing large-scale patent or paper data. This may be due to performance bottlenecks in the document parser or vector model when processing complex documents, or if the
PARSE_FILE_TIMEOUT_SECONDSparameter is set too low.
Verification of Configuration
- For typical peptide drug queries, verify that the recalled documents contain core peptide names, targets, and key experimental data from the query.
- Check documents imported using the image vectorization feature. When queries involve specific molecular structures or experimental charts, verify if corresponding image-containing document segments are effectively recalled.
- Select a batch of data containing specialized terms, abbreviations, and complex sentences for import. Review import logs to confirm no parsing errors or vectorization failures, and verify the retrieval accuracy of this content through queries.
- Compare recall results under different
Similarity threshold(Similarity Threshold) settings. Observe changes in the precision and recall rate of recalled documents to determine a threshold range that balances business needs.
The values given are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.